UroGen Pharma Submits Investigational New Drug (IND) Application for UGN-102 (VesiGel) Pharmaceutical Investing
NanoSphere Health Sciences’ Brand Evolve Formulas Expanding Rapidly Across Colorado and Beyond Biotech Investing
XBiotech Announces First Patient in Phase 2 Study Evaluating Subcutaneous MABp1 in Patients with Hidradenitis Suppurativa Biotech Investing
MediciNova Announces Clinical Data from Subgroup Analyses of Completed Clinical Trial of MN-166 (ibudilast) in ALS Biotech Investing
Inspire Medical Announces Aetna Coverage for Inspire Therapy for the Treatment of Obstructive Sleep Apnea Medical Device Investing
